|
1
|
Rocchi A, Pellegrini S, Siciliano G and
Murri L: Causative and susceptibility genes for Alzheimer’s
disease: a review. Brain Res Bull. 61:1–24. 2003.
|
|
2
|
Götz J, Streffer JR, David D, et al:
Transgenic animal models of Alzheimer’s disease and related
disorders: histopathology, behavior and therapy. Mol Psychiatry.
9:664–683. 2004.
|
|
3
|
Head E, Pop V, Sarsoza F, et al:
Amyloid-beta peptide and oligomers in the brain and cerebrospinal
fluid of aged canines. J Alzheimers Dis. 20:637–646.
2010.PubMed/NCBI
|
|
4
|
Kragh PM, Nielsen AL, Li J, et al:
Hemizygous minipigs produced by random gene insertion and handmade
cloning express the Alzheimer’s disease-causing dominant mutation
APPsw. Transgenic Res. 18:545–558. 2009.PubMed/NCBI
|
|
5
|
Jang G, Kim MK, Oh HJ, et al: Birth of
viable female dogs produced by somatic cell nuclear transfer.
Theriogenology. 67:941–947. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Duyckaerts C, Potier MC and Delatour B:
Alzheimer disease models and human neuropathology: similarities and
differences. Acta Neuropathol. 115:5–38. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hong SG, Kim MK, Jang G, et al: Generation
of red fluorescent protein transgenic dogs. Genesis. 47:314–322.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hossein MS, Kim MK, Jang G, et al: Effects
of thiol compounds on in vitro maturation of canine oocytes
collected from different reproductive stages. Mol Reprod Dev.
74:1213–1220. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lee BC, Kim MK, Jang G, et al: Dogs cloned
from adult somatic cells. Nature. 436:6412005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Spanopoulou E, Giguere V and Grosveld F:
The functional domains of the murine Thy-1 gene promoter. Mol Cell
Biol. 11:2216–2228. 1991.PubMed/NCBI
|
|
11
|
Dudal S, Krzywkowski P, Paquette J, et al:
Inflammation occurs early during the Abeta deposition process in
TgCRND8 mice. Neurobiol Aging. 25:861–871. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Spires TL and Hyman BT: Transgenic models
of Alzheimer’s disease: learning from animals. NeuroRx. 2:423–437.
2005.
|
|
13
|
Friedman D, Honig LS and Scarmeas N:
Seizures and epilepsy in Alzheimer’s disease. CNS Neurosci Ther.
18:285–294. 2012.
|
|
14
|
Irizarry MC, Jin S, He F, et al: Incidence
of new-onset seizures in mild to moderate Alzheimer disease. Arch
Neurol. 69:368–372. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Larner AJ and Marson AG: Epileptic
seizures in Alzheimer’s disease: another fine MESS? J Alzheimers
Dis. 25:417–419. 2011.
|
|
16
|
Pandis D and Scarmeas N: Seizures in
Alzheimer disease: clinical and epidemiological data. Epilepsy
Curr. 12:184–187. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Picco A, Archetti S, Ferrara M, et al:
Seizures can precede cognitive symptoms in late-onset Alzheimer’s
disease. J Alzheimers Dis. 27:737–742. 2011.PubMed/NCBI
|
|
18
|
Apostolova LG, Green AE, Babakchanian S,
et al: Hippocampal atrophy and ventricular enlargement in normal
aging, mild cognitive impairment (MCI), and Alzheimer Disease.
Alzheimer Dis Assoc Disord. 26:17–27. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chou YY, Leporé N, Avedissian C, et al:
Mapping correlations between ventricular expansion and CSF amyloid
and tau biomarkers in 240 subjects with Alzheimer’s disease, mild
cognitive impairment and elderly controls. Neuroimage. 46:394–410.
2009.PubMed/NCBI
|
|
20
|
Ferrarini L, Palm WM, Olofsen H, et al:
MMSE scores correlate with local ventricular enlargement in the
spectrum from cognitively normal to Alzheimer disease. Neuroimage.
39:1832–1838. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nestor SM, Rupsingh R, Borrie M, et al:
Ventricular enlargement as a possible measure of Alzheimer’s
disease progression validated using the Alzheimer’s disease
neuroimaging initiative database. Brain. 131:2443–2454.
2008.PubMed/NCBI
|
|
22
|
Glass CK, Saijo K, Winner B, Marchetto MC
and Gage FH: Mechanisms underlying inflammation in
neurodegeneration. Cell. 140:918–934. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dyrks T, Weidemann A, Multhaup G, et al:
Identification, transmembrane orientation and biogenesis of the
amyloid A4 precursor of Alzheimer’s disease. EMBO J. 7:949–957.
1988.PubMed/NCBI
|
|
24
|
Selkoe DJ: Alzheimer’s disease: genes,
proteins, and therapy. Physiol Rev. 81:741–766. 2001.
|
|
25
|
Sisodia SS: Beta-amyloid precursor protein
cleavage by a membrane-bound protease. Proc Natl Acad Sci USA.
89:6075–6079. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sarasa M and Pesini P: Natural
non-trasgenic animal models for research in Alzheimer’s disease.
Curr Alzheimer Res. 6:171–178. 2009.PubMed/NCBI
|
|
27
|
Head E: Combining an antioxidant-fortified
diet with behavioral enrichment leads to cognitive improvement and
reduced brain pathology in aging canines: strategies for healthy
aging. Ann NY Acad Sci. 1114:398–406. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Siwak-Tapp CT, Head E, Muggenburg BA,
Milgram NW and Cotman CW: Region specific neuron loss in the aged
canine hippocampus is reduced by enrichment. Neurobiol Aging.
29:39–50. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Head E, Mehta R, Hartley J, et al: Spatial
learning and memory as a function of age in the dog. Behav
Neurosci. 109:851–858. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Adams B, Chan A, Callahan H, et al: Use of
a delayed non-matching to position task to model age-dependent
cognitive decline in the dog. Behav Brain Res. 108:47–56. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Smith DR, Hoyt EC, Gallagher M, Schwabe RF
and Lund PK: Effect of age and cognitive status on basal level AP-1
activity in rat hippocampus. Neurobiol Aging. 22:773–786. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sokol DL and Gewirtz AM: Gene therapy:
basic concepts and recent advances. Crit Rev Eukaryot Gene Expr.
6:29–57. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Martin SB, Dowling AL and Head E:
Therapeutic interventions targeting Beta amyloid pathogenesis in an
aging dog model. Curr Neuropharmacol. 9:651–661. 2011. View Article : Google Scholar : PubMed/NCBI
|
